Barlow Wealth Partners’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$917K Hold
2,205
0.1% 65
2026
Q1
$712K Hold
2,205
0.08% 69
2025
Q4
$822K Sell
2,205
-4
-0.2% -$1.35K 0.09% 66
2025
Q3
$763K Sell
2,209
-17,461
-89% -$5.43M 0.08% 68
2025
Q2
$6.89M Buy
19,670
+17,390
+763% +$6.99M 0.82% 35
2025
Q1
$961K Buy
2,280
+30
+1% +$12K 0.13% 57
2024
Q4
$876K Sell
2,250
-25,105
-92% -$10.5M 0.11% 63
2024
Q3
$13.5M Buy
27,355
+369
+1% +$197K 1.76% 28
2024
Q2
$13.8M Buy
26,986
+759
+3% +$401K 1.91% 21
2024
Q1
$13M Buy
26,227
+24,050
+1,105% +$12M 1.78% 22
2023
Q4
$1.03M Buy
+2,177
New +$1.01M 0.15% 66

Other funds holding ELV

Barlow Wealth Partners's ELV Position: Q2 2026 in Review

Barlow Wealth Partners held its Elevance Health (ELV) position steady in Q2 2026 at 2,205 shares worth $917K. The position accounts for 0.1% of the portfolio, ranked #65.

Barlow Wealth Partners first reported a position in ELV in Q4 2023 and has held it in 11 quarters since. The position peaked at $13.8M in Q2 2024. 637 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Barlow Wealth Partners held 2,205 shares of Elevance Health worth $917K as of Q2 2026.
  • Barlow Wealth Partners left its Elevance Health share count unchanged in Q2 2026.
  • Elevance Health made up 0.1% of Barlow Wealth Partners's portfolio in Q2 2026, its #65 holding.
  • Barlow Wealth Partners first reported a position in Elevance Health in Q4 2023 and has held it in 11 quarters since.
  • Barlow Wealth Partners's Elevance Health position peaked at $13.8M in Q2 2024.
  • 637 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Barlow Wealth Partners's 13F filing for Q2 2026, filed 14 Jul 2026.